These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8216345)

  • 21. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system.
    Smith BR; Born JL; Garcia DJ
    Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties.
    Flockhart IR; Sheldon PW; Stratford IJ; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Jul; 34(1):91-4. PubMed ID: 309446
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent.
    Mulcahy RT; Gipp JJ; Ublacker GA; McClelland RA
    Biochem Pharmacol; 1990 Dec; 40(12):2671-6. PubMed ID: 2260990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione conjugates of misonidazole.
    Varghese AJ
    Biochem Biophys Res Commun; 1983 May; 112(3):1013-20. PubMed ID: 6847675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-enhanced reduction and covalent binding of [2-3H]misonidazole in the perfused rat liver.
    Smith BR
    Biochem Pharmacol; 1984 Apr; 33(8):1379-81. PubMed ID: 6201179
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorescent probes for cellular hypoxia: lack of transfer of fluorescence between cells in vitro.
    Olive PL
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1947-54. PubMed ID: 2414255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system.
    Rauth AM; McClelland RA; Michaels HB; Battistella R
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1323-6. PubMed ID: 6236187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of misonidazole to EMt6 and V79 spheroids.
    Franko AJ; Chapman JD; Koch CJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):737-9. PubMed ID: 7107407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Skov KA; Adomat H; Chaplin DJ; Farrell NP
    Anticancer Drug Des; 1990 Feb; 5(1):121-8. PubMed ID: 2156514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
    Adams GE; Stratford IJ
    Biochem Pharmacol; 1986 Jan; 35(1):71-6. PubMed ID: 2934067
    [No Abstract]   [Full Text] [Related]  

  • 36. Killing of EMT-6 cells by decays from isotopes incorporated on sensitizer adducts.
    Roa WH; Chapman JD
    Radiat Res; 1992 Nov; 132(2):248-53. PubMed ID: 1438707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioreductive markers for hypoxic cells: 2-nitroimidazoles with biotinylated 1-substituents.
    Hodgkiss RJ; Parrick J; Porssa M; Stratford MR
    J Med Chem; 1994 Dec; 37(25):4352-6. PubMed ID: 7996546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of nitroheterocyclic compounds by mammalian tissues in vivo.
    Yeung TC; Sudlow G; Koch RL; Goldman P
    Biochem Pharmacol; 1983 Jul; 32(14):2249-53. PubMed ID: 6870947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry].
    Shimizu Y
    Yakugaku Zasshi; 2018; 138(11):1345-1352. PubMed ID: 30381642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.